Last reviewed · How we verify

Epinephrine concentration of 1:1000000

Al-Azhar University · Phase 3 active Small molecule

Epinephrine concentration of 1:1000000 is a Sympathomimetic amine / Adrenergic agonist Small molecule drug developed by Al-Azhar University. It is currently in Phase 3 development for Anaphylaxis (emergency treatment), Cardiac arrest (ACLS protocol), Severe hypotension.

Epinephrine is an alpha and beta-adrenergic agonist that stimulates sympathetic nervous system receptors to increase heart rate, blood pressure, and bronchial airway diameter.

Epinephrine is an alpha and beta-adrenergic agonist that stimulates sympathetic nervous system receptors to increase heart rate, blood pressure, and bronchial airway diameter. Used for Anaphylaxis (emergency treatment), Cardiac arrest (ACLS protocol), Severe hypotension.

At a glance

Generic nameEpinephrine concentration of 1:1000000
SponsorAl-Azhar University
Drug classSympathomimetic amine / Adrenergic agonist
TargetAlpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
ModalitySmall molecule
Therapeutic areaEmergency Medicine / Cardiovascular / Anesthesia
PhasePhase 3

Mechanism of action

Epinephrine binds to alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors throughout the body. This activation increases cardiac contractility and heart rate (beta-1), causes vasoconstriction (alpha-1), and promotes bronchodilation (beta-2). The 1:1000000 concentration indicates an extremely dilute formulation, typically used for local anesthetic adjuvants or specific clinical applications requiring minimal systemic exposure.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Epinephrine concentration of 1:1000000

What is Epinephrine concentration of 1:1000000?

Epinephrine concentration of 1:1000000 is a Sympathomimetic amine / Adrenergic agonist drug developed by Al-Azhar University, indicated for Anaphylaxis (emergency treatment), Cardiac arrest (ACLS protocol), Severe hypotension.

How does Epinephrine concentration of 1:1000000 work?

Epinephrine is an alpha and beta-adrenergic agonist that stimulates sympathetic nervous system receptors to increase heart rate, blood pressure, and bronchial airway diameter.

What is Epinephrine concentration of 1:1000000 used for?

Epinephrine concentration of 1:1000000 is indicated for Anaphylaxis (emergency treatment), Cardiac arrest (ACLS protocol), Severe hypotension, Adjuvant to local anesthetics (vasoconstrictor at 1:1000000 dilution).

Who makes Epinephrine concentration of 1:1000000?

Epinephrine concentration of 1:1000000 is developed by Al-Azhar University (see full Al-Azhar University pipeline at /company/al-azhar-university).

What drug class is Epinephrine concentration of 1:1000000 in?

Epinephrine concentration of 1:1000000 belongs to the Sympathomimetic amine / Adrenergic agonist class. See all Sympathomimetic amine / Adrenergic agonist drugs at /class/sympathomimetic-amine-adrenergic-agonist.

What development phase is Epinephrine concentration of 1:1000000 in?

Epinephrine concentration of 1:1000000 is in Phase 3.

What are the side effects of Epinephrine concentration of 1:1000000?

Common side effects of Epinephrine concentration of 1:1000000 include Tachycardia, Hypertension, Tremor, Anxiety, Headache, Palpitations.

What does Epinephrine concentration of 1:1000000 target?

Epinephrine concentration of 1:1000000 targets Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors and is a Sympathomimetic amine / Adrenergic agonist.

Related